Stock ORMP ORAMED PHARMACEUTICALS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Oramed Pharmaceuticals Inc.

Equities

ORMP

US68403P2039

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
2.395 USD +0.63% Intraday chart for Oramed Pharmaceuticals Inc. +1.91% +3.68%
May. 09 Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Mar. 19 Oramed Pharmaceuticals Inc. Appoints Yehuda Reznick as Director, Effective as of April 1, 2024 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ORAMED PHARMACEUTICALS INC. Stock Oramed Pharmaceuticals Inc.
 97.04M - - - -
MODERNA, INC. Stock Moderna, Inc.
 44.96B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.65B
LONZA GROUP AG Stock Lonza Group AG
 41.85B
CELLTRION, INC. Stock Celltrion, Inc.
 29.04B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.08B
  1. Stock Market
  2. Equities
  3. ORMP Stock
  4. Charts Oramed Pharmaceuticals Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW